Invention Grant
US08575125B2 Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
失效
CB2受体表达的选择性抑制剂和/或用于治疗肥胖和肥胖相关疾病的活性
- Patent Title: Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
- Patent Title (中): CB2受体表达的选择性抑制剂和/或用于治疗肥胖和肥胖相关疾病的活性
-
Application No.: US13297993Application Date: 2011-11-16
-
Publication No.: US08575125B2Publication Date: 2013-11-05
- Inventor: Vanessa Deveaux , Fatima Teixeira Clerc , Sylvie Manin , Sophie Lotersztajn , Ariane Mallat , Jeanne Tran-Van-Nhieu
- Applicant: Vanessa Deveaux , Fatima Teixeira Clerc , Sylvie Manin , Sophie Lotersztajn , Ariane Mallat , Jeanne Tran-Van-Nhieu
- Applicant Address: FR Paris
- Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
- Current Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
- Current Assignee Address: FR Paris
- Agency: Stites & Harbison, PLLC
- Agent B. Aaron Schulman
- Priority: EP07290411 20070404
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/63
Abstract:
The invention relates to a method for treating and/or preventing obesity and/or obesity-related disorders by administering to a subject in need thereof a selective inhibitor of cannabinoid type 2 (CB2) receptor expression.
Public/Granted literature
Information query
